Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of Zhigancao Tang Granule for heart failure with preserved ejection fraction due to Qi-Yin deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zhigancao Tang Granule

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: UNKNOWN